Update on Phase 3 Librexia ACS Trial
Go back to Update on Phase 3 Librexia ACS Trial| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 55.39 +0.39 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.00 | 52 Week High | $77.12 | |||
| Open | $55.37 | 52 Week Low | $49.03 | |||
| Day High | $56.19 | P/E | 35.97 | |||
| Day Low | $55.02 | EPS | $1.54 | |||
| Volume | 15,981,422 | |||||
